The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
39
No.
15
April 12, 2013
- “Start Fighting” Says Former Rep. John Porter To Crowd of 12,000 at AACR Washington Rally
- Appropriations 2014: Obama Plan Good News for NIH, Bad News For Some Oncologists
- House Launches Probe of NCI Spending On Cancer Communications, Education
- In Brief: Dmitrovsky Named Provost at MD Anderson; Paulsen Leaves To Chair Duke Radiology
TCL
Vol.
39
No.
16
April 19, 2013
- Georgetown-Hackensack Consortium Plan Points to Rising Value of NCI Designation
- In Myriad Case, the Supreme Court Hears About Tree Leaves, Baseball and Cookies
- Guest Editorial by Robert Cook-Deegan: Myriad Case Ruling Likely to Concur With DOJ Arguments
- Amgen Pays $24.9 Million To Settle Kickback Charges
CCL
Vol.
36
No.
4
April 26, 2013
- Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable
- Intermittent Androgen Deprivation Therapy Not Equal to Continuous Treatment, Study Finds
- Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies
- Avoiding Mediastinal Radiation Can Improve Patient Outcomes
- Obese Men With Benign Biopsy At High Risk for Prostate Cancer
- Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients
- Study Finds That CTC Was Used Correctly In Medicare Patients
- ASCO Draft Recommendations Define Meaningful Trial Outcomes
- Phase II Study Cohort Fails To Overcome Erlotinib Resistance
- Alcohol Consumption Does Not Impact Survival of Breast Cancer
- Study: Blood Test More Accurate Than Traditional Tumor Biopsy
- European Treatment Regimen Less Toxic Than American Method
- Study Finds Nearly Two-Thirds Of Children Return to Hospital Following Stem Cell Transplant
- NCI CTEP Approved Trials For the Month of April
- FDA Breakthrough Designation Granted to Pfizer’s Palbociclib
TCL
Vol.
39
No.
20
May 17, 2013
- CPRIT Likely to Get Funding For Two Years; DePinho Announces Austerity Measures
- Guest Editorial: As ACS Turns 100, Society President Calls For Tools To Finish the Fight Against Cancer
- ODAC Unanimously Rejects Melblez, Citing Lower Survival
- Sequestration: $1.71 Billion Cut to NIH Budget Will Reduce Number of RPGs
- In Brief: Sparano Named Vice Chair of ECOG-ACRIN
